S&P 500
(-0.34%) 5 018.39 points
Dow Jones
(0.23%) 37 903 points
Nasdaq
(-0.33%) 15 605 points
Oil
(0.37%) $79.29
Gas
(0.88%) $1.949
Gold
(1.01%) $2 334.30
Silver
(1.05%) $27.03
Platinum
(1.28%) $967.10
USD/EUR
(0.04%) $0.933
USD/NOK
(0.01%) $11.03
USD/GBP
(-0.04%) $0.798
USD/RUB
(0.06%) $93.51

Realaus laiko atnaujinimai Avinger Inc [AVGR]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Medical Instruments & Supplies
Atnaujinta1 geg. 2024 @ 23:00

2.51% $ 3.68

Live Chart Being Loaded With Signals

Commentary (1 geg. 2024 @ 23:00):
Profile picture for Avinger Inc

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally...

Stats
Šios dienos apimtis 3 649.00
Vidutinė apimtis 54 545.00
Rinkos kapitalizacija 6.26M
EPS $0 ( 2024-03-20 )
Kita pelno data ( $-1.350 ) 2024-05-08
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.160
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2024-03-05 Zhao Jonathon Zhong Buy 0 Common stock
2024-03-05 Zhao Jonathon Zhong Buy 0 Series F Convertible Preferred Stock
2024-01-18 Patel Himanshu Buy 55 553 Common Stock
2024-01-18 Patel Himanshu Sell 24 616 Common Stock
2024-01-18 Soinski Jeffrey M Buy 74 071 Common Stock
INSIDER POWER
79.25
Last 96 transactions
Buy: 1 530 711 | Sell: 343 509

Avinger Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
MPAA0.967
CAAS0.962
SXTC0.961
INVZ0.958
NVX0.958
PLUG0.957
ARVL0.956
BPYPN0.955
USEG0.954
ARDS0.954
10 Labiausiai neigiamai susiję koreliacijos
BRIVU-0.946
PPYAU-0.941
TYHT-0.933
RAM-0.931
CPTA-0.929
NVCN-0.926
EVOP-0.925
RPHM-0.92
IMRX-0.917
HSTM-0.916

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Avinger Inc Finansinės ataskaitos

Annual 2023
Pajamos: $7.65M
Bruto pelnas: $2.00M (26.18 %)
EPS: $-23.31
FY 2023
Pajamos: $7.65M
Bruto pelnas: $2.00M (26.18 %)
EPS: $-23.31
FY 2022
Pajamos: $8.27M
Bruto pelnas: $2.65M (32.08 %)
EPS: $-41.83
FY 2021
Pajamos: $10.13M
Bruto pelnas: $3.42M (33.80 %)
EPS: $-4.57

Financial Reports:

No articles found.

Avinger Inc

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.